NCT00965107

Brief Summary

This study is aimed at increasing the safety of the use of anaesthesia in an elderly population (\> 60 years). Patients with decreased physiological reserve, including all elderly patients, have an increased risk of getting an erroneous induction bolus. This project will investigate how fast elderly patients (\> 60 years) fall asleep during bolus induction of anaesthesia with two of the most used hypnotics, thiopental and propofol, evaluated with BIS-monitoring and clinical signs of anaesthetic depth. The hemodynamic response will also be evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Sep 2009

Shorter than P25 for phase_4

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 25, 2009

Completed
7 days until next milestone

Study Start

First participant enrolled

September 1, 2009

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
Last Updated

March 9, 2010

Status Verified

February 1, 2010

Enrollment Period

6 months

First QC Date

August 24, 2009

Last Update Submit

March 8, 2010

Conditions

Outcome Measures

Primary Outcomes (1)

  • "Onset-time" defined as the time from started induction bolus to: - Time to BIS-value <50.

    120 seconds

Secondary Outcomes (4)

  • Hemodynamical effect (bloodpressure/pulse) every 60 seconds.

    120 seconds

  • "Onset-time" defined as the time from started induction bolus to: - Time to loss of grip.

    120 seconds

  • "Onset-time" defined as the time from started induction bolus to: - Time to eye closure.

    120 seconds

  • "Onset-time" defined as the time from started induction bolus to: - Time to ciliary reflex cessation.

    120 seconds

Study Arms (2)

Thiopental

EXPERIMENTAL

Thiopental for induction of anaesthesia.

Drug: Thiopental

Propofol

ACTIVE COMPARATOR

Propofol for induction of anaesthesia.

Drug: Propofol

Interventions

Thiopental given as a bolus dose of 2,5 mg/kg.

Also known as: Thiomebumalnatrium, thiomebumal
Thiopental

Propofol given as a bolus dose of 1 mg/kg.

Propofol

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective surgical patients above 60 years of age, with an indication of general anaesthesia during surgery.
  • Informed consent.
  • The patient must be legally competent.
  • The patient must be able to read and understand Danish.

You may not qualify if:

  • Known allergic reactions to thiopental, propofol, lidocaine or alfentanil
  • "Body Mass Index" (BMI) \<18 and \> 35.
  • NYHA-class \> 2.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Anesthesia, Center of Head and Orthopedics, Copenhagen University Hospital Rigshospitalet

Copenhagen, 2100, Denmark

Location

Department of Anesthesia, Juliane Marie Center, Copenhagen University Hospital Rigshospitalet

Copenhagen, 2100, Denmark

Location

MeSH Terms

Interventions

ThiopentalPropofol

Intervention Hierarchy (Ancestors)

ThiobarbituratesBarbituratesPyrimidinonesPyrimidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Lars Rasmussen, MD, PHD

    Rigshospitalet, Denmark

    PRINCIPAL INVESTIGATOR
  • Martin K Soerensen, MD

    Rigshospitalet, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 24, 2009

First Posted

August 25, 2009

Study Start

September 1, 2009

Primary Completion

March 1, 2010

Study Completion

March 1, 2010

Last Updated

March 9, 2010

Record last verified: 2010-02

Locations